» Articles » PMID: 6066157

Factors Influencing Growth Inhibition of Mycoplasma Pneumoniae by Immune Sera

Overview
Date 1967 Oct 1
PMID 6066157
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.

Fernald G, CLYDE W Infect Immun. 1970; 1(6):559-65.

PMID: 16557776 PMC: 415942. DOI: 10.1128/iai.1.6.559-565.1970.


An experimental model for human mycoplasma disease.

CLYDE Jr W Yale J Biol Med. 1968; 40(5-6):436-43.

PMID: 5673852 PMC: 2591633.


Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains.

Lipman R, CLYDE Jr W, Denny F J Bacteriol. 1969; 100(2):1037-43.

PMID: 5359607 PMC: 250191. DOI: 10.1128/jb.100.2.1037-1043.1969.


Investigation into rabbit infusion media for the growth of Mycoplasma gallisepticum antigens for inoculation into rabbits.

Bradbury J, Jordan F J Hyg (Lond). 1971; 69(1):73-82.

PMID: 5291753 PMC: 2130842. DOI: 10.1017/s0022172400021264.


Modifications of the growth inhibition test and its application to human T-mycoplasmas.

Black F Appl Microbiol. 1973; 25(4):528-33.

PMID: 4572983 PMC: 380855. DOI: 10.1128/am.25.4.528-533.1973.